Detalhe da pesquisa
1.
Casirivimab and imdevimab: Cost-effectiveness analysis of the treatment based on monoclonal antibodies on outpatients with Covid-19.
PLoS One
; 18(2): e0279022, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-36763607
2.
Estimation Model for Healthcare Costs and Intensive Care Units Access for Covid-19 Patients and Evaluation of the Effects of Remdesivir in the Portuguese Context: Hypothetical Study.
Clin Drug Investig
; 42(4): 345-354, 2022 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-35298832
3.
Modeling the Potential Impact of Remdesivir Treatment for Hospitalized Patients with COVID-19 in Saudi Arabia on Healthcare Resource Use and Direct Hospital Costs: A Hypothetical Study.
Clin Drug Investig
; 42(8): 669-678, 2022 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-35838880
4.
Cost-Effectiveness Analysis of Tapentadol Versus Oxycodone/Naloxone in both Branded and Generic Formulations in Patients with Musculoskeletal Pain.
Clin Drug Investig
; 41(10): 875-883, 2021 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-34524651